Insulin, epidermal growth factor and fibroblast growth factor elicit distinct patterns of protein tyrosine

J M Kyriakis1, J Avruch

  • 1Medical Services and Diabetes Unit, Massachusetts General Hospital, Boston 02129.

Insights

Insulin, epidermal growth factor (EGF), and fibroblast growth factor (FGF) trigger distinct tyrosine phosphorylation patterns in BC3H1 cells. Each growth factor targets specific proteins, revealing unique substrate specificities and regulatory properties of receptor tyrosine kinases.

Area of Science:

  • Cellular signaling pathways
  • Receptor tyrosine kinase (RTK) activity
  • Protein phosphorylation

Background:

  • BC3H1 cells are a murine muscle-like cell line used to study cellular responses.
  • Insulin, EGF, and FGF are key signaling molecules that bind to receptor tyrosine kinases.
  • Tyrosine phosphorylation is a critical post-translational modification regulating cellular processes.

Purpose of the Study:

  • To identify and characterize polypeptide substrates phosphorylated at tyrosine residues in response to insulin, EGF, and FGF.
  • To compare the substrate specificity and kinetic/regulatory properties of these three receptor tyrosine kinases.
  • To investigate the effects of phorbol esters on hormone-induced tyrosine phosphorylation.

Main Methods:

  • Immunoblotting with antiphosphotyrosine antibodies to detect phosphorylated proteins.
  • Subcellular fractionation and lectin chromatography to classify substrates.
  • Dose-response and temporal analyses of phosphorylation.
  • Assessment of phorbol ester effects on hormone signaling.

Main Results:

  • Each ligand (insulin, EGF, FGF) induced tyrosine phosphorylation of a distinct set of polypeptide substrates.
  • Dose-response curves were superimposable for each ligand, but temporal patterns varied significantly.
  • Insulin induced rapid, sustained phosphorylation; EGF showed a delayed peak and decline; FGF had a late onset and rapid peak.
  • Phorbol esters differentially inhibited EGF and FGF responses but did not affect insulin signaling.

Conclusions:

  • Insulin, EGF, and FGF exhibit fundamentally distinct substrate specificities as receptor tyrosine kinases.
  • Kinetic and regulatory properties of these RTKs differ significantly in situ.
  • The study highlights the complex and specific nature of signaling initiated by different growth factors in the same cell type.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...